Search clinical trials for: 18F-PMPBB3 (APN-1607) PET imaging

Total 294 results

Northwestern University
National Cancer Institute (NCI)

Recruiting

rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance

Prostate Adenocarcinoma | Stage I Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8

United States
Jonsson Comprehensive Cancer Center

Completed

Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases

Rheumatoid Arthritis | Systemic Lupus Erythematosus | Crohn Disease | Takayasu Arteritis | Autoimmune Disease | Inflammatory Disorder

United States
University Medical Center Groningen

Recruiting

Lung Nodule Detection Using Ultra-long FOV PET/CT

Lung Cancer

Netherlands
Imperial College London
Medical Research Council; ECMC

Recruiting

D4 Choline Breast PET/CT

Metastatic Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast Cancer

United Kingdom
Amsterdam UMC, location VUmc
Radboud University Medical Center; Leiden University Medical Center; Academisch... and other collaborators

Completed

Early Biomarker With 18F-FDG PET for Treatment Optimization of Anti-EGFR Therapy in Patients With Metastatic Colorectal Cancer.

Colorectal Cancer

Netherlands
Stanford University
GE Healthcare

Completed

Use of PET/MR Imaging in Chronic Pain

Chronic Pain

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
Melanoma Research Alliance

Completed

PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy

Melanoma | Non-small Cell Lung Cancer (NSCLC) | Renal Cell Carcinoma (RCC)

United States
National Cancer Institute (NCI)

Completed

MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme

Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma

United States
University of Wisconsin, Madison
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Not yet recruiting

FDG PET/MR Imaging of Peripheral Pain Generators

Pain | Nociceptive Pain

United States
Queen's Medical Center
National Cancer Institute (NCI)

Completed

PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection

Adult Hepatocellular Carcinoma | Localized Resectable Adult Liver Carcinoma

United States
Robert Flavell, MD, PhD
National Cancer Institute (NCI)

Recruiting

Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma

Multiple Myeloma | Plasma Cell Myeloma

United States
University of Utah

Terminated

Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water

Brain Cancer

United States
Washington University School of Medicine
St. Louis Children's Hospital

Recruiting

Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism (18FDOPA HI)

Hyperinsulinism

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

FDG PET-MRI for the Diagnosis of Spinal Cord Lesions

Spinal Cord Neoplasm

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases

Metastatic Malignant Solid Neoplasm | Metastatic Malignant Neoplasm in the Brain

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

18F-FDG PET-MRI for Planning and Follow-Up of Patients With Spine Tumors Treated With Spine Stereotactic Radiosurgery

Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Active, not recruiting

Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement

Melanoma of Unknown Primary | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8 | Recurrent Cutaneous Melanoma | Metastatic Malignant Neoplasm in Lymph Node

United States
Balaji Tamarappoo

Completed

TRACER [F-18] RDG-K5 Carotid Plaque Imaging Study (K5-C200)

Carotid Arteries

United States
Emory University
National Cancer Institute (NCI)

Recruiting

BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients With Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy

Hepatocellular Carcinoma | BCLC Stage B Hepatocellular Carcinoma | BCLC Stage C Hepatocellular Carcinoma | BCLC Stage A Hepatocellular Carcinoma

United States
Guangxi Medical University

Unknown

MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma

Lymphoma

China
OHSU Knight Cancer Institute
Oregon Health and Science University; Progenics Pharmaceuticals, Inc.

Not yet recruiting

Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

Prostate Adenocarcinoma | Castration Resistant Prostate Cancer | Castration Sensitive Prostate Cancer

United States
Cedars-Sinai Medical Center

Completed

18F-fluoride (18F-NaF) PET for Identifying Coronary Atherosclerotic Plaques

Coronary Artery Disease | Atherosclerotic Plaque

United States
ECOG-ACRIN Cancer Research Group

Not yet recruiting

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

Glioblastoma, IDH-Wildtype
University Medical Center Groningen
Amsterdam UMC, location VUmc; University Medical Center Nijmegen

Active, not recruiting

IMaging PAtients for Cancer Drug selecTion - Metastatic Breast Cancer (IMPACT-MBC)

Metastatic Breast Cancer

Netherlands
University of Washington
National Cancer Institute (NCI)

Completed

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Male Breast Carcinoma

United States
Memorial Sloan Kettering Cancer Center

Withdrawn

A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer

Breast Cancer | Metastatic Breast Cancer | Breast Carcinoma | Metastatic Breast Carcinoma | Female Breast Cancer
The First Affiliated Hospital of Xiamen University

Recruiting

ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer

Solid Tumor | Thyroid Cancer | Tumor | Positron-Emission Tomography

China
Guido A. Davidzon, MD, SM

Completed

[18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers

Glioblastoma | Healthy Subject | Intracranial Neoplasm

United States
University of Utah

Terminated

Multi-Tracer Positron Emission Tomography in Patients With Solid Tumors

Malignant Neoplasm

United States
University Hospital, Toulouse

Completed

Evaluation de O-(2-[18F]-Fluoroethyl)-L-Tyrosine, a New Tracer PET, in the Diagnosis of Low Grade Glioma (PET-FETII)

Low Grade Glioma

France
Stanford University
National Cancer Institute (NCI)

Completed

Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers

Pancreatic Carcinoma | Healthy Subject

United States
University Health Network, Toronto

Completed

PET MRI Study in Patients With Cardiac Sarcoidosis

Sarcoidosis | Inflammatory Cardiomyopathy

Canada
Turku University Hospital
University of Turku

Completed

Novel Imaging in Staging of Primary Prostate Cancer (PROSTAGE)

High Risk Prostate Cancer

Finland
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer

Stage IA Cervical Cancer | Stage IB Cervical Cancer | Stage IA1 Cervical Cancer | Stage IA2 Cervical Cancer | Stage IB1 Cervical Cancer | Stage IB2 Cervical Cancer | Stage IB3 Cervical Cancer

United States
National Cancer Institute (NCI)

Completed

Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer

Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer

Differentiated Thyroid Gland Carcinoma | Thyroid Gland Follicular Carcinoma | Thyroid Gland Papillary Carcinoma

United States
IRCCS San Raffaele

Completed

FAZA PET IMAGING IN DETECTING LYMPH NODE METASTASES IN RENAL CELL CARCINOMA PATIENTS (FAZA)

Renal Cell Carcinoma (RCC)

Italy
Assistance Publique - Hôpitaux de Paris
Institut Pasteur, Paris France

Completed

PET/CT Guided Antifungal Stewardship in Invasive Pulmonary Aspergillosis (OPTIFIL)

Aspergillosis and Haematological Malignancy

France
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

Cholangiocarcinoma | Adult Hepatocellular Carcinoma | Resectable Hepatocellular Carcinoma | Benign Liver Tumor | Metastases to Liver

United States
University of Texas Southwestern Medical Center

Recruiting

PET/MR for Characterization of Renal Masses (RMs)

Renal Cell Carcinoma | Renal Tumor | Renal Tumor, Benign

United States
University of Southern California
National Cancer Institute (NCI); National Institute for Biomedical Imaging...

Terminated

18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer

Prostate Neoplasm

United States
Maastricht University Medical Center

Recruiting

Molecular Imaging of Plaque Vulnerability (PARISK)

Plaque, Atherosclerotic

Netherlands
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Withdrawn

Digital PET Scan for the Prediction of Outcomes in Patients With Locally Advanced Oropharyngeal Cancer

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma... and other conditions

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Breast Carcinoma | Fallopian Tube Carcinoma | Ovarian Carcinoma | Primary Peritoneal Carcinoma | Solid Neoplasm

United States
Stanford University
National Cancer Institute (NCI)

Completed

[18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer

Liver Cirrhosis | Adult Liver Carcinoma

United States
Central Hospital, Nancy, France
Institut National de la Santé Et de la Recherche Médicale, France

Completed

Endoprosthesis Treatment Effects on Human Abdominal Aorta Aneurysms (AAA) Metabolic Activity (AAAendo)

Abdominal Aortic Aneurysm

France
Ottawa Heart Institute Research Corporation

Terminated

Multi-modality Imaging of Ischemia With 18F-FDG PET and CTA

Myocardial Ischemia

Canada
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

PET/MRI and PET/CT in Diagnosing Younger Patients With Cancer

Childhood Cancer

United States
Oxford University Hospitals NHS Trust
GE Healthcare; University of Oxford

Terminated

RGD-PET-CT in Cancer Angiogenesis

Carcinoma, Renal Cell

United Kingdom
Dr. Markus Hartenbach

Completed

Clinical Value of FEC-PET Combined With Endorectal MRI for Pre-therapeutic Staging of Prostate Cancer (FEC-PET/MRI)

Prostate Cancer

Germany

Search clinical trials for: 18F-PMPBB3 (APN-1607) PET imaging

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations